Original Research

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation

van Rossem K, Lowe JA

Clinical Pharmacology: Advances and Applications 2013, 5:23-31

Published Date: 30 January 2013